We are live on ! Find out more
TBRA

Tobira Therapeutics, Inc. Common Stock
TBRA

Delisted

TBRA was delisted on the 31st of October, 2016.

Back to rankings

68 hedge funds and large institutions have $505M invested in Tobira Therapeutics, Inc. Common Stock in 2016 Q3 according to their latest regulatory filings, with 36 funds opening new positions, 20 increasing their positions, 5 reducing their positions, and 13 closing their positions.

New
Increased
Maintained
Reduced
Closed

300% more repeat investments, than reductions

Existing positions increased: 20 | Existing positions reduced: 5

244% more capital invested

Capital invested by funds: $147M → $505M (+$358M)

177% more first-time investments, than exits

New positions opened: 36 | Existing positions closed: 13

51% more funds holding

Funds holding: 45 → 68 (+23)

25% less funds holding in top 10

Funds holding in top 10: 4 → 3 (-1)

72% less call options, than puts

Call options by funds: $1.18M | Put options by funds: $4.17M

Holders
68
Holders Change
+23
Holders Change %
+51.11%
% of All Funds
1.81%
Holding in Top 10
3
Holding in Top 10 Change
-1
Holding in Top 10 Change %
-25%
% of All Funds
0.08%
New
36
Increased
20
Reduced
5
Closed
13
Calls
$1.18M
Puts
$4.17M
Net Calls
-$3M
Net Calls Change
-$3M

Top Buyers

Rank Fund Capital Flow
1
PCM
Pentwater Capital Management
Florida
+$41.3M
2
PC
Paulson & Co
New York
+$11.9M
3
GL
Governors Lane
New York
+$10.3M
4
BG
Baupost Group
Massachusetts
+$1.79M
5
Susquehanna International Group
Susquehanna International Group
Pennsylvania
+$1.78M

Top Sellers

Rank Fund Capital Flow
1
NHAS
Novo Holdings A/S
Denmark
-$25.5M
2
Fidelity Investments
Fidelity Investments
Massachusetts
-$16.3M
3
BI
BVF Inc
California
-$9.53M
4
A
Abingworth
United Kingdom
-$7.38M
5
BB
BB Biotech
Switzerland
-$5.88M
Name Holding Trade Value Shares
Change 		Change in
Stake
TAL
26
TIG Advisors LLC
New York
$1.49M +$418K +37,454 New
BIM
27
BlackRock Investment Management
Delaware
$1.41M +$37.2K +3,330 +10%
Bank of New York Mellon
28
Bank of New York Mellon
New York
$1.26M +$120K +10,728 +51%
Deutsche Bank
29
Deutsche Bank
Germany
$1.04M +$65.4K +5,865 +29%
JMPWA
30
JP Morgan Private Wealth Advisors
California
$994K +$279K +25,000 New
AAM
31
Alpine Associates Management
Florida
$832K +$234K +20,932 New
California State Teachers Retirement System (CalSTRS)
32
California State Teachers Retirement System (CalSTRS)
California
$746K +$2.23K +200 +1%
Morgan Stanley
33
Morgan Stanley
New York
$661K +$174K +15,614 +1,561%
TA
34
Teachers Advisors
New York
$576K – – –
Charles Schwab
35
Charles Schwab
California
$558K – – –
GI
36
GAMCO Investors
Connecticut
$528K +$148K +13,275 New
TC
37
TFS Capital
Pennsylvania
$515K -$329K -29,450 -69%
PAMP
38
Polar Asset Management Partners
Ontario, Canada
$497K +$139K +12,500 New
CS
39
Credit Suisse
Switzerland
$456K +$128K +11,454 New
New York State Common Retirement Fund
40
New York State Common Retirement Fund
New York
$405K +$89.3K +8,000 +364%
VKH
41
Virtu KCG Holdings
New York
$363K +$102K +9,131 New
Jane Street
42
Jane Street
New York
$358K +$100K +8,997 New
RhumbLine Advisers
43
RhumbLine Advisers
Massachusetts
$331K +$93.1K +8,341 New
FO
44
FT Options
Illinois
$322K +$90.4K +8,106 New
Citigroup
45
Citigroup
New York
$296K +$83K +7,440 New
CL
46
CSS LLC
Illinois
$278K +$78K +6,995 New
HM
47
Harvest Management
New York
$258K +$72.5K +6,500 New
NFA
48
Nationwide Fund Advisors
Ohio
$225K +$2.69K +241 +4%
TSS
49
Two Sigma Securities
New York
$217K +$60.9K +5,457 New
Wells Fargo
50
Wells Fargo
California
$210K +$59.1K +5,296 New
1
2
3 4

TBRA Hedge Fund Activity: Q3 2016 in Review

68 of the 3,748 institutional investors tracked by Wall St. Rank reported a position in Tobira Therapeutics, Inc. Common Stock (TBRA) for Q3 2016, worth a combined $505M — up 244% from $147M a quarter earlier.

Buyers outnumbered sellers: 36 funds opened new TBRA positions and 13 closed out — a net gain of 23 holders — while 20 added to existing stakes and 5 trimmed.

The largest buyer was Pentwater Capital Management, opening a new position worth an estimated $41.3M. The largest seller was Novo Holdings A/S, exiting entirely with an estimated $25.5M sold.

  • 68 institutional investors held Tobira Therapeutics, Inc. Common Stock (TBRA) as of Q3 2016, up from 45 in Q2 2016.
  • Funds reported $505M of Tobira Therapeutics, Inc. Common Stock stock for Q3 2016, up 244% quarter-over-quarter.
  • 36 funds opened new Tobira Therapeutics, Inc. Common Stock positions in Q3 2016 and 13 closed out, a net change of +23 holders.
  • The largest Tobira Therapeutics, Inc. Common Stock buyer in Q3 2016 was Pentwater Capital Management, an estimated $41.3M added.
  • The largest Tobira Therapeutics, Inc. Common Stock seller in Q3 2016 was Novo Holdings A/S, an estimated $25.5M sold.

Based on aggregated 13F filings for Q3 2016.